Cascade Technologies Appoints Dr. Jerome Swartz to Lead Its Advisory Board

Date Announced: 29 Jun 2012

Highly Accomplished Technology Executive Brings Four Decades of Successful Industry Experience.

BEVERLY HILLS, CA--(Marketwire - Jun 29, 2012) - Cascade Technologies Corp. (OTCBB: CSDT) and its wholly owned subsidiary, Spectral Molecular Imaging, Inc. ("SMI"), today announced the appointment of Jerome Swartz, Ph.D. to lead its four-member Advisory Board.

A highly respected scientist, Dr. Swartz is best known for having co-founded Symbol Technologies in 1973, which began as a leader in handheld laser-based bar code scanners. Under his guidance as Chairman and Chief Scientist, Symbol Technologies became a leading manufacturer and worldwide supplier of mobile data capture and delivery equipment. He led Symbol Technologies to win the U.S. National Medal of Technology, the country's highest honor for technology innovation. The company was acquired by Motorola for $3.9 billion in January 2007.

Among his many professional achievements, Swartz is a recognized expert in the engineering physics fields of electro-optics, laser systems and optical design, with particular application to new product development. He is credited with more than 200 U.S. patents and has authored seminal papers in this field.

Cascade Technologies President Gene Scher said, "It is a great honor for us to announce Dr. Jerry Swartz's appointment to lead the Cascade Advisory Board. Dr. Swartz is a world-renowned leader in his field. For the past 30 years, he has collaborated with and supported many of the leading U.S. biomedical institutions, and his contacts in this sector are unrivaled. He will fulfill an important strategic role on the Advisory Board, facilitating Cascade development and speeding up execution of our business plan."

Dr. Daniel L. Farkas, Cascade Chairman and CEO, said, "We are delighted and proud to have an Advisory Board of world-class leaders and innovators, now fully representing the fields that matter most to the company: research, technology transfer and productization, business and the clinical realm. The addition of Dr. Swartz's exceptional talents and experience will prove, in our view, invaluable to our efforts. We look forward to his many significant contributions, and on behalf of all Cascade shareholders, I warmly welcome him to the Company."

Commenting on his appointment, Dr. Swartz said, "Cascade's Spectral Molecular Imaging has an innovative, solid medical technology platform offering many potential public health benefits for individuals as well as for clinical care delivery and insurance systems worldwide. I am pleased to accept an advisory leadership position so early in the Company's development as we pursue successful commercialization."

Source: Cascade Technologies

Contact

E-mail: via web site

Web Site: www.opmol.com